ANI Pharmaceuticals receives FDA approval for ANDA for Fluoxetine Oral Solution

ANI Pharmaceuticals, announced that the Company received U.S. Food and Drug Administration approval for the Abbreviated New Drug Application for Fluoxetine Oral Solution, USP 20 mg/5 mL. ANI’s Fluoxetine Oral Solution is the generic version of the Reference Listed Drug Prozac.